Arax Advisory Partners
DRUG icon

Arax Advisory Partners’s Bright Minds Biosciences DRUG Stock Holding History

Arax Advisory Partners’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$772 Buy
+11
New +$864 ﹤0.01% 4960
2025
Q4 		– Sell
-24
Closed -$1.46K – 4200
2025
Q3 		$1.46K Buy
+24
New +$932 ﹤0.01% 3175

Other funds holding DRUG

Jupiter Topco
Jupiter Topco New York $245B AUM
Cormorant Asset Management
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vivo Capital
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Braidwell
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Arax Advisory Partners's DRUG Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Bright Minds Biosciences (DRUG) in Q2 2026: 11 shares worth $772. The stake represents ﹤0.01% of the portfolio and ranks #4960 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in DRUG as recently as Q3 2025.

Arax Advisory Partners first reported a position in DRUG in Q3 2025 and has held it in 2 quarters since. The position peaked at $1.46K in Q3 2025. 99 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • Arax Advisory Partners held 11 shares of Bright Minds Biosciences worth $772 as of Q2 2026.
  • Bright Minds Biosciences was a new Arax Advisory Partners position in Q2 2026.
  • Bright Minds Biosciences made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4960 holding.
  • Arax Advisory Partners first reported a position in Bright Minds Biosciences in Q3 2025 and has held it in 2 quarters since.
  • Arax Advisory Partners's Bright Minds Biosciences position peaked at $1.46K in Q3 2025.
  • 99 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.